Mu and kappa opioid receptors in periaqueductal gray and rostral ventromedial medulla

Related Experiment Video

Updated: Oct 29, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

H B Gutstein1, A Mansour, S J Watson

  • 1Mental Health Research Institute, The University of Michigan, Ann Arbor 48109-0720, USA.

Neuroreport
|July 17, 1998
PubMed

Insights

This study investigated the anatomical overlap of mu and kappa opioid receptors in the periaqueductal gray (PAG) and rostral ventromedial medulla (RVM). Findings reveal significant co-localization, suggesting opioid receptor interactions in pain modulation.

Area of Science:

  • Neuroscience
  • Pain research
  • Opioid receptor pharmacology

Background:

  • The periaqueductal gray (PAG) and rostral ventromedial medulla (RVM) are key brainstem regions involved in pain modulation.
  • Kappa opioids may antagonize mu opioid effects in the RVM, but their precise anatomical relationship is unclear.

Purpose of the Study:

  • To investigate the anatomical co-localization of mu and kappa opioid receptors in the PAG and RVM.
  • To provide an anatomical basis for understanding opioid receptor interactions in pain pathways.

Main Methods:

  • Utilized immunocytochemistry and in situ hybridization techniques on brain slices.
  • Examined the distribution of mu and kappa opioid receptor immunoreactivity (IR) and mRNA in the PAG and RVM.

Main Results:

  • Demonstrated considerable anatomical overlap of mu and kappa opioid receptor IR and mRNA in both the RVM and PAG.
  • Identified significant co-localization of these opioid receptors within the studied brain regions.

Conclusions:

  • The findings provide anatomical support for observed behavioral and electrophysiological data in the RVM.
  • Suggest potential modulatory interactions between mu and kappa opioid systems within the PAG and RVM for pain control.

More Related Videos

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior12:20

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Brainstem: Control Centers of Medulla01:21

Brainstem: Control Centers of Medulla

The medulla oblongata is a crucial part of the brainstem responsible for controlling various autonomic and involuntary functions. It contains several nuclei, including the olivary, cuneate, gracile, and solitary nuclei.
Olivary Nucleus
The olivary nucleus, or inferior olivary nucleus, is located within the ventrolateral part of the medulla oblongata. It is primarily involved in motor coordination and motor learning. The olivary nucleus receives input from the spinal cord, cerebellum, and motor...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...